Clin2
NCT07697274Possibly a fitNot yet recruiting

Hyaluronidase for hard skin on fingers in scleroderma

Systemic SclerosisSclerodactyly

Part of Immune system & allergy, Skin clinical trials.

This trial tests if an enzyme called hyaluronidase can soften and improve the hard, tight skin on fingers caused by systemic sclerosis (scleroderma). It may help increase flexibility and comfort.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
10 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 59 years old
  • You have a confirmed diagnosis of systemic sclerosis (scleroderma)
  • You have hard, tight skin on your fingers (sclerodactyly)
  • You are not pregnant or breastfeeding
  • You have not had recent changes to your immune-suppressing medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06133244Recruiting
Hand function in systemic sclerosis

This study looks at how systemic sclerosis (a condition that can cause hardening of the skin) affects hand function. It aims to understand the problems people face and find better ways to help.

Utrecht
NCT03211793Recruiting· Phase 1/Phase 2
Cell treatment for painful hand sores in systemic sclerosis

This trial tests a cell-based treatment (mesenchymal stromal cells) to help heal painful finger/toe ulcers in people with systemic sclerosis. It is for ulcers that did not improve after a specific IV medicine called prostacyclins.

Utrecht
NCT04356755Recruiting· Phase 2
Injections under the skin to heal scleroderma finger ulcers

This Phase 2 study tests whether injections under the skin can help heal painful, poor-circulation (ischemic) finger ulcers caused by scleroderma. It is for people whose ulcers have not improved with usual care.

Grenoble
NCT06058091Recruiting· Phase 1/Phase 2
Cell injection therapy for systemic sclerosis

This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.

Nanjing, Jiangsu
NCT07360808Recruiting
Fat Cell Therapy for Hand Problems in Scleroderma

This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.

Guangzhou, Guangdong
NCT07759557Not yet recruiting· Phase 3
Botulinum toxin pad for finger pain in scleroderma

This study tests a skin patch with botulinum toxin to ease blood vessel spasms in the fingers of people with scleroderma, which can cause pain and sores. It may help improve blood flow and reduce finger discomfort.

Hear when a new Systemic Sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.